Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases

Sfaxi F, Scamuffa N, Lalou C, Ma J, Metrakos P, Siegfried G, Ragg H, Bikfalvi A, Calvo F, Khatib A-M (2014)
Oncotarget 5(12): 4195-4210.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Sfaxi, Fatma; Scamuffa, Nathalie; Lalou, Claude; Ma, Jia; Metrakos, Peter; Siegfried, Geraldine; Ragg, HermannUniBi; Bikfalvi, Andreas; Calvo, Fabien; Khatib, Abdel-Majid
Abstract / Bemerkung
Liver is the most common site of metastasis from colorectal cancers, and liver of patients with liver colorectal metastasis have abnormal levels of the proprotein convertases (PCs). These proteases are involved in the activation and/or expression of various colon cancer-related mediators, making them promising targets in colorectal liver metastasis therapy. Here, we revealed that the serpin Spn4 from Drosophila melanogaster inhibits the activity of all the PCs found in the constitutive secretory pathway and represses the metastatic potential of the colon cancer cells HT-29 and CT-26. In these cells, Spn4A inhibited the processing of the PCs substrates IGF-1R and PDGF-A that associated their reduced anchorage-independent growth, invasiveness and survival in response to apoptotic agents. In vivo, Spn4A-expressing tumor cells showed repressed subcutaneous tumor development and liver metastases formation in response to their intrasplenic inoculation. In these cells Spn4A induced the expression of molecules with anti-metastatic functions and inhibited expression of pro-tumorigenic molecules. Taken together, our findings identify Spn4A as the only endogenous inhibitor of all the constitutive secretory pathway PCs, which is able to repress the metastatic potential of colon cancer cells. These results suggest the potential use of Spn4A and/or derivates as a useful adduct colorectal liver metastasis prevention.
Stichworte
PACE4; PC5; PC7; mitogenic activity; Spn4A; Furin
Erscheinungsjahr
2014
Zeitschriftentitel
Oncotarget
Band
5
Ausgabe
12
Seite(n)
4195-4210
ISSN
1949-2553
Page URI
https://pub.uni-bielefeld.de/record/2690864

Zitieren

Sfaxi F, Scamuffa N, Lalou C, et al. Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases. Oncotarget. 2014;5(12):4195-4210.
Sfaxi, F., Scamuffa, N., Lalou, C., Ma, J., Metrakos, P., Siegfried, G., Ragg, H., et al. (2014). Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases. Oncotarget, 5(12), 4195-4210.
Sfaxi, F., Scamuffa, N., Lalou, C., Ma, J., Metrakos, P., Siegfried, G., Ragg, H., Bikfalvi, A., Calvo, F., and Khatib, A. - M. (2014). Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases. Oncotarget 5, 4195-4210.
Sfaxi, F., et al., 2014. Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases. Oncotarget, 5(12), p 4195-4210.
F. Sfaxi, et al., “Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases”, Oncotarget, vol. 5, 2014, pp. 4195-4210.
Sfaxi, F., Scamuffa, N., Lalou, C., Ma, J., Metrakos, P., Siegfried, G., Ragg, H., Bikfalvi, A., Calvo, F., Khatib, A.-M.: Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases. Oncotarget. 5, 4195-4210 (2014).
Sfaxi, Fatma, Scamuffa, Nathalie, Lalou, Claude, Ma, Jia, Metrakos, Peter, Siegfried, Geraldine, Ragg, Hermann, Bikfalvi, Andreas, Calvo, Fabien, and Khatib, Abdel-Majid. “Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases”. Oncotarget 5.12 (2014): 4195-4210.

5 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomes.
Villoutreix BO, Khatib AM, Cheng Y, Miteva MA, Maréchal X, Vidal J, Reboud-Ravaux M., Oncotarget 8(6), 2017
PMID: 28060729
Combining targeted therapy with immunotherapy. Can 1+1 equal more than 2?
Robert L, Ribas A, Hu-Lieskovan S., Semin Immunol 28(1), 2016
PMID: 26861544
The proprotein convertase furin is required to maintain viability of alveolar rhabdomyosarcoma cells.
Jaaks P, Meier G, Alijaj N, Brack E, Bode P, Koscielniak E, Wachtel M, Schäfer BW, Bernasconi M., Oncotarget 7(47), 2016
PMID: 27572312

37 References

Daten bereitgestellt von Europe PubMed Central.

Structure of a serpin-protease complex shows inhibition by deformation.
Huntington JA, Read RJ, Carrell RW., Nature 407(6806), 2000
PMID: 11057674
Neuroendocrine secretory protein 7B2: structure, expression and functions.
Mbikay M, Seidah NG, Chretien M., Biochem. J. 357(Pt 2), 2001
PMID: 11439082
Functional characterization of ProSAAS: similarities and differences with 7B2.
Fortenberry Y, Hwang JR, Apletalina EV, Lindberg I., J. Biol. Chem. 277(7), 2001
PMID: 11719503
Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy.
Khatib AM, Siegfried G, Chretien M, Metrakos P, Seidah NG., Am. J. Pathol. 160(6), 2002
PMID: 12057895
Furin at the cutting edge: from protein traffic to embryogenesis and disease.
Thomas G., Nat. Rev. Mol. Cell Biol. 3(10), 2002
PMID: 12360192
Precursor processing by kex2/furin proteases.
Rockwell NC, Krysan DJ, Komiyama T, Fuller RS., Chem. Rev. 102(12), 2002
PMID: 12475200
Serpin structure, mechanism, and function.
Gettins PG., Chem. Rev. 102(12), 2002
PMID: 12475206
The cystatin-related epididymal spermatogenic protein inhibits the serine protease prohormone convertase 2.
Cornwall GA, Cameron A, Lindberg I, Hardy DM, Cormier N, Hsia N., Endocrinology 144(3), 2003
PMID: 12586766
The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis.
Siegfried G, Basak A, Cromlish JA, Benjannet S, Marcinkiewicz J, Chretien M, Seidah NG, Khatib AM., J. Clin. Invest. 111(11), 2003
PMID: 12782675
Serpins: structure, function and molecular evolution.
van Gent D, Sharp P, Morgan K, Kalsheker N., Int. J. Biochem. Cell Biol. 35(11), 2003
PMID: 12824063
The Spn4 gene of Drosophila encodes a potent furin-directed secretory pathway serpin.
Richer MJ, Keays CA, Waterhouse J, Minhas J, Hashimoto C, Jean F., Proc. Natl. Acad. Sci. U.S.A. 101(29), 2004
PMID: 15247425
Simultaneous production of IGF-I and EGF competing growth factors by HT-29 human colon cancer line.
Culouscou JM, Remacle-Bonnet M, Garrouste F, Marvaldi J, Pommier G., Int. J. Cancer 40(5), 1987
PMID: 3500134
Processing specificity and biosynthesis of the Drosophila melanogaster convertases dfurin1, dfurin1-CRR, dfurin1-X, and dfurin2.
De Bie I, Savaria D, Roebroek AJ, Day R, Lazure C, Van de Ven WJ, Seidah NG., J. Biol. Chem. 270(3), 1995
PMID: 7836354
The inhibitory specificity of human proteinase inhibitor 8 is expanded through the use of multiple reactive site residues.
Dahlen JR, Foster DC, Kisiel W., Biochem. Biophys. Res. Commun. 244(1), 1998
PMID: 9514892
alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent.
Jean F, Stella K, Thomas L, Liu G, Xiang Y, Reason AJ, Thomas G., Proc. Natl. Acad. Sci. U.S.A. 95(13), 1998
PMID: 9636142
Inhibition of furin by serpin Spn4A from Drosophila melanogaster.
Oley M, Letzel MC, Ragg H., FEBS Lett. 577(1-2), 2004
PMID: 15527779
PACE4 expression in mouse basal keratinocytes results in basement membrane disruption and acceleration of tumor progression.
Bassi DE, Lopez De Cicco R, Cenna J, Litwin S, Cukierman E, Klein-Szanto AJ., Cancer Res. 65(16), 2005
PMID: 16103082
Proprotein convertases: "master switches" in the regulation of tumor growth and progression.
Bassi DE, Fu J, Lopez de Cicco R, Klein-Szanto AJ., Mol. Carcinog. 44(3), 2005
PMID: 16167351
Abnormal expression and processing of the proprotein convertases PC1 and PC2 in human colorectal liver metastases.
Tzimas GN, Chevet E, Jenna S, Nguyen DT, Khatib AM, Marcus V, Zhang Y, Chretien M, Seidah N, Metrakos P., BMC Cancer 5(), 2005
PMID: 16293189
The serpin proteinase inhibitor 8: an endogenous furin inhibitor released from human platelets.
Leblond J, Laprise MH, Gaudreau S, Grondin F, Kisiel W, Dubois CM., Thromb. Haemost. 95(2), 2006
PMID: 16493485
The Spn4 gene from Drosophila melanogaster is a multipurpose defence tool directed against proteases from three different peptidase families.
Bruning M, Lummer M, Bentele C, Smolenaars MM, Rodenburg KW, Ragg H., Biochem. J. 401(1), 2007
PMID: 16989645
Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer.
Page RE, Klein-Szanto AJ, Litwin S, Nicolas E, Al-Jumaily R, Alexander P, Godwin AK, Ross EA, Schilder RJ, Bassi DE., Cell. Oncol. 29(4), 2007
PMID: 17641413
Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1.
Lapierre M, Siegfried G, Scamuffa N, Bontemps Y, Calvo F, Seidah NG, Khatib AM., Cancer Res. 67(19), 2007
PMID: 17909005
Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells.
Scamuffa N, Siegfried G, Bontemps Y, Ma L, Basak A, Cherel G, Calvo F, Seidah NG, Khatib AM., J. Clin. Invest. 118(1), 2008
PMID: 18064302
Inhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p53, CDKN2A and N-Ras genes.
Lalou C, Scamuffa N, Mourah S, Plassa F, Podgorniak MP, Soufir N, Dumaz N, Calvo F, Basset-Seguin N, Khatib AM., PLoS ONE 5(4), 2010
PMID: 20404912
Plasminogen activator inhibitor 1 is an intracellular inhibitor of furin proprotein convertase.
Bernot D, Stalin J, Stocker P, Bonardo B, Scroyen I, Alessi MC, Peiretti F., J. Cell. Sci. 124(Pt 8), 2011
PMID: 21406565
Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer.
Buck E, Mulvihill M., Expert Opin Investig Drugs 20(5), 2011
PMID: 21446886
Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer.
Senzer N, Barve M, Kuhn J, Melnyk A, Beitsch P, Lazar M, Lifshitz S, Magee M, Oh J, Mill SW, Bedell C, Higgs C, Kumar P, Yu Y, Norvell F, Phalon C, Taquet N, Rao DD, Wang Z, Jay CM, Pappen BO, Wallraven G, Brunicardi FC, Shanahan DM, Maples PB, Nemunaitis J., Mol. Ther. 20(3), 2011
PMID: 22186789
Prodomain of the proprotein convertase subtilisin/kexin Furin (ppFurin) protects from tumor progression and metastasis.
Scamuffa N, Sfaxi F, Ma J, Lalou C, Seidah N, Calvo F, Khatib AM., Carcinogenesis 35(3), 2013
PMID: 24127186

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 24961901
PubMed | Europe PMC

Suchen in

Google Scholar